• Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Average Rating of "Buy" from Analysts

    المصدر: Buzz FX / 21 فبراير 2025 04:26:12   America/New_York


    Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Average Rating of "Buy" from Analysts Written by MarketBeat February 21, 2025 Share Link copied to clipboard. Trevi Therapeutics, Inc. ( NASDAQ:TRVI - Get Free Report ) has been given a consen
    Read more...
شارك على،